tirzepatide birth defects Is it safe to take (glucagon-like peptide-1 (GLP-1) receptor agonist) during pregnancy? TLDR on GLP-1 receptor agonists

STUDY 1 286,000 records were included 10/10,000 (0.1%) were diagnosed with gastroparesis at least 6 months later (the rate in the general non-medicated population is 0.04%) STUDY 2 Compared those on GLP-1 meds vs

These studies clearly showed that the simultaneous activation of GIP and GLP1 receptors was anti-obesogenic and could be utilized for its therapeutic potential

While insurance isn't required, it can be helpful while using LifeMD, particularly for testing and medications

[DOI] [PMC free article] [PubMed] [Google Scholar] Al-kuraishy HM, Al-Gareeb AI, Elekhnawy E, et al

Novo Nordisk believes this new facility will help avoid shortages in the future